WESTMINSTER, Colo., USA (February 22, 2012) – Surefire Medical, Inc., a Colorado-based medical device company, announced today that Robert M. Holburn, Jr. will join the company as Chief Financial Officer.

“With more than 35 years of senior financial management experience, Bob brings a wealth of knowledge and expertise to our organization that will enable us to meet our financial growth objectives,” said Jim Chomas, CEO of Surefire Medical. “Bob also has a stellar track record of successes with start-up companies, so we are thrilled to have him as part of our management team.”

Prior to joining the Surefire team, Holburn held the position of Vice President and CFO of Medivance, a medical device manufacturer that was recently acquired by C.R. Bard, Inc. (BCR). During his career, he also financially managed a number of multinational organizations while at Texas Instruments; successfully managed an initial public and secondary offering for Rogue Wave Software; and has participated in executing and integrating numerous company and technology acquisitions. 

David Perez to Testify before U.S. House Energy and Commerce Health Subcommittee
Hearing Scheduled to Discuss Reauthorization of the Medical Device User Fee Act 

Denver Business Journal 

SomaLogic, Inc., announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, an initiative that seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. Urs Ochsner, head of the Infectious Diseases Research Group at SomaLogic, will pursue an innovative research project to identify and validate TB biomarkers, titled SOMAmer-based detection of tuberculosis biomarkers. 

New Medical Device User Fee Agreement Will Improve FDA Performance, Provide Accountability, Predictability
Deal Sets Important Goal For Total Review Times  

Colorado (Jan 31, 2012) - Poudre Valley Health System (PVHS) and the University of Colorado Hospital (UCH) have finalized a joint operating agreement that creates a health system its leaders say will widen health care services and provide unparalleled patient care in the Rocky Mountain region. 

WASHINGTON — Brandishing brochures showing people jogging in Stapleton, mountain biking in Boulder and skiing on fresh powder in the high country, a cabal of lawyers, politicians and scientists is making a full-throated beg to the federal government to put a U.S. patent satellite office in Colorado. 

BOULDER, Colorado – January 31, 2012 – InDevR, Inc., a Boulder-based biotechnology company developing advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the appointment of Dr. Michael Artinger as Vice President of Commercial Operations and Mr. Craig Hoechstetter as Director of Sales and Customer Support.   

Denver, CO, January 31, 2012 – Colorado BioScience Association (CBSA) will host the fourth annual “BioScience Day at the Capitol” on February 2nd, 7:30-9:00 a.m. at the Legislative Services Building, A, 14th & Sherman (South side of Capitol).  The event will bring together industry leaders and legislators to support the growth of bioscience in Colorado.

The announcement is made by Holli Rieble, CBSA President and CEO, who recently stated; “We are honored to have the support of our legislators and look forward to working together to support the industry this session.”